NCT06208514Recruiting

Brief Pain Exposure Therapy for Fibromyalgia (BPET) Study

Name: Clinical Trial NCT06208514
Creator: University of Michigan
Keywords: Fibromyalgia, Brief pain exposure therapy (BPET), behavioral, clinical trial, United States of America

Brief Pain Exposure Therapy for Fibromyalgia - A Pilot Study

University of MichiganClinicalTrials.govbehavioral

Verified

Study focus

Disease/Condition: Fibromyalgia
Drug/Device/Intervention: Brief pain exposure therapy (BPET)
Study type: Interventional
Intervention type: behavioral

Sponsor & location

Primary sponsor: University of Michigan
Location: Ann Arbor, United States of America

Timeline & enrollment

Phase: N/A
Start date: Mar 04, 2024
End date: Jul 01, 2025
Enrollment: 30 participants

Primary outcome

Change in pain intensity based on the Numeric Pain Rating Scale between day 1 (T1) and day 60 (T5)

Summary

This study is intended to test whether a brief Zoom-based behavioral treatment can help adults with fibromyalgia learn effective strategies for reducing pain, disability and other problems that can come with fibromyalgia (such as depression or anxiety).

ICD-10 classifications

FibromyalgiaMyalgiaFibrothoraxCervicalgiaEpidemic myalgia

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06208514
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06208514 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Michigan and is currently Recruiting. The study focuses on Fibromyalgia. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.